Our R&D Pipeline

R&D Strategy

Osmotica's Research and Development Pipeline maximizes the synergies of the Company's expertise, capacity and intellectual property. Our R&D pipeline is divided into three distinct categories:

1. An internal proprietary development program focused on new and improved treatments for Parkinson's disease and related neurological disorders. Our R&D pipeline targets unmet medical and commercial needs.

2. Development projects leveraging our core capabilities to develop partnered products for commercialization outside our therapeutic focus. Typically these products include challenging development hurdles that require our type of specialized expertise.

3. Drug delivery technology innovation to enhance the scope of our drug delivery solutions. This technology pipeline includes continued advances and improvements to the Osmodex® technologies as well as other controlled release delivery technologies.

OVERVIEW OUR BUSINESS OUR HISTORY OUR LOCATIONS DEVELOPMENT FACILITIES OUR MANAGEMENT TEAM OUR BOARD OF DIRECTORS OUR INVESTORS OUR EMPLOYEES WHAT'S NEW OVERVIEW PARTNERING WITH OSMOTICA OUT-LICENSING OPPORTUNITIES IN-LICENSING INTERESTS PROJECT MANAGEMENT OVERVIEW OSMODEX FAMILY OTHER TECHNOLOGIES INTELLECTUAL PROPERTY R&D STRATEGY NEUROLOGY PIPELINE PARTNERED PIPELINE TECHNOLOGY PIPELINE SCIENTIFIC ADVISORY BOARD LICENSED PRODUCTS APPROVED IN U.S. APPROVED IN OTHER COUNTRIES CONTACT US

Version 8 October 6, 2009 | Copyright © 2009 Osmotica Pharmaceutical Corp., All rights reserved. | Terms and Conditions